Expectant Management
Treatment for Ectopic Pregnancy
Effectiveness
65%
Safety Score
70%
Clinical Trials
8
Participants
6K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Time to Effect
weeks to months for spontaneous resolution
Treatment Duration
weeks to months of close monitoring
Evidence Quality
MODERATEConfidence Score
75%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,500
Side Effect Mgmt:$2,550
Total Annual:$4,050
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
0.7
Outcome-Based Costs
Cost per Responder
$6,230
Cost per Remission
$6,230
Comparison vs Methotrexate
Cost Difference
+$2,550/year
More expensive
QALY Difference
-0.10 QALYs
Worse outcomes
Dominance
No dominance
Expectant Management Outcomes
for Ectopic Pregnancy
Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+65%
Remission Rate
+65%
Common Side Effects
Anxiety/stress
+70%
Prolonged monitoring
+100%
Need for subsequent intervention (MTX or surgery)
+35%
Tubal rupture (life-threatening)
+7%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
4 completed trials for Expectant Management in Ectopic Pregnancy
Reproductive Outcomes After a Previous Episode of Tubal Ectopic Pregnancy in Patients Managed Expectantly and Surgically
NCT05479786COMPLETED
312 participants
OBSERVATIONAL
Started: Jan 1, 2012
Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy
NCT01876004COMPLETEDPHASE4
25 participants
INTERVENTIONAL
São Paulo, Brazil
Started: Sep 1, 2011
Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
NCT02152696COMPLETEDPHASE3
255 participants
INTERVENTIONAL
San Francisco, United States +16 more
Started: Jul 25, 2014
The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis
NCT02977117COMPLETEDPHASE2
59 participants
INTERVENTIONAL
Hillerød, Denmark
Started: Dec 1, 2016